SG10202111233SA - Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting - Google Patents
Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sortingInfo
- Publication number
- SG10202111233SA SG10202111233SA SG10202111233SA SG10202111233SA SG10202111233SA SG 10202111233S A SG10202111233S A SG 10202111233SA SG 10202111233S A SG10202111233S A SG 10202111233SA SG 10202111233S A SG10202111233S A SG 10202111233SA SG 10202111233S A SG10202111233S A SG 10202111233SA
- Authority
- SG
- Singapore
- Prior art keywords
- technology
- flow cytometry
- reporter expression
- bulk sorting
- rapid bulk
- Prior art date
Links
- 230000002238 attenuated effect Effects 0.000 title 1
- 238000000684 flow cytometry Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- G01N15/149—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70592—CD52
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562239515P | 2015-10-09 | 2015-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202111233SA true SG10202111233SA (en) | 2021-11-29 |
Family
ID=57211576
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201802829YA SG11201802829YA (en) | 2015-10-09 | 2016-10-07 | Early post-transfection isolation of cells (epic) for biologics production |
SG11201802823VA SG11201802823VA (en) | 2015-10-09 | 2016-10-07 | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
SG10202111233SA SG10202111233SA (en) | 2015-10-09 | 2016-10-07 | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201802829YA SG11201802829YA (en) | 2015-10-09 | 2016-10-07 | Early post-transfection isolation of cells (epic) for biologics production |
SG11201802823VA SG11201802823VA (en) | 2015-10-09 | 2016-10-07 | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
Country Status (10)
Country | Link |
---|---|
US (4) | US11635363B2 (en) |
EP (2) | EP3359666A1 (en) |
CN (3) | CN108368505B (en) |
AU (2) | AU2016335699A1 (en) |
CA (2) | CA3001238A1 (en) |
HK (1) | HK1259493A1 (en) |
IL (4) | IL258538B2 (en) |
MX (1) | MX2018004366A (en) |
SG (3) | SG11201802829YA (en) |
WO (2) | WO2017062724A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015191508A1 (en) | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
JP6401871B2 (en) | 2014-11-05 | 2018-10-10 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | AADC polynucleotide for the treatment of Parkinson's disease |
EP3218484A4 (en) | 2014-11-14 | 2018-05-30 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
SG11201703419UA (en) | 2014-11-14 | 2017-05-30 | Voyager Therapeutics Inc | Modulatory polynucleotides |
EP3230441A4 (en) | 2014-12-12 | 2018-10-03 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
SG11201802829YA (en) | 2015-10-09 | 2018-05-30 | Genzyme Corp | Early post-transfection isolation of cells (epic) for biologics production |
EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
WO2017189964A2 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
WO2017201258A1 (en) | 2016-05-18 | 2017-11-23 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
EP3458588A4 (en) | 2016-05-18 | 2020-01-15 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
CL2016001661A1 (en) * | 2016-06-29 | 2017-03-03 | Univ Chile | Hybrid promoter of ß-actin (from cricetulus griseus) and cytomegalovirus (cmv), with a region rich in dinucleotides, cytosine-guanine, vectors, cell lines, procedure to produce recombinant proteins. |
EP3831281A1 (en) | 2016-08-30 | 2021-06-09 | The Regents of The University of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
US20180119192A1 (en) * | 2016-10-07 | 2018-05-03 | Genzyme Corporation | Early post-transfection isolation of cells (epic) for biologics production |
WO2018204803A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
JP2020518258A (en) | 2017-05-05 | 2020-06-25 | ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. | Amyotrophic lateral sclerosis (ALS) treatment composition and method |
JOP20190269A1 (en) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
US11497576B2 (en) | 2017-07-17 | 2022-11-15 | Voyager Therapeutics, Inc. | Trajectory array guide system |
WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
AU2018352236A1 (en) | 2017-10-16 | 2020-04-23 | The Curators Of The University Of Missouri | Treatment of amyotrophic lateral sclerosis (ALS) |
JP2023554593A (en) | 2020-11-19 | 2023-12-28 | ジェンザイム・コーポレーション | FLOW CYTOMETRY ATTENUATED REPORTER EXPRESSION (FLARE) MULTI REPORTER SYSTEM AND ITS USE |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4818700A (en) | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
US4812405A (en) | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
US4937190A (en) | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
CA2063799A1 (en) | 1989-07-24 | 1991-01-25 | Frank S. Genbauffe | Prevention of internal initiation |
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
WO1994026087A2 (en) | 1993-05-14 | 1994-11-24 | Connor Kim C O | Recombinant protein production and insect cell culture and process |
US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
US5955349A (en) | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
US5736383A (en) | 1996-08-26 | 1998-04-07 | Zymogenetics, Inc. | Preparation of Pichia methanolica auxotrophic mutants |
JP2002513285A (en) | 1997-02-25 | 2002-05-08 | キュービーアイ エンタープライジズ リミテッド | High translation efficiency IRES sequence and expression vector containing this sequence |
US7001733B1 (en) * | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
US6258559B1 (en) | 1999-03-22 | 2001-07-10 | Zymogenetics, Inc. | Method for producing proteins in transformed Pichia |
WO2001004306A1 (en) | 1999-07-12 | 2001-01-18 | Genentech, Inc. | Expression vectors and methods |
US20050005310A1 (en) * | 1999-07-12 | 2005-01-06 | Genentech, Inc. | Expression vectors and methods |
WO2001057212A1 (en) | 2000-02-02 | 2001-08-09 | Iconix Pharmaceuticals, Inc. | Rapid, parallel identification of cell lines |
WO2002070710A1 (en) | 2001-03-01 | 2002-09-12 | University Of California | Method to identify ires elements |
DE10143238A1 (en) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Identification of eukaryotic internal ribosome entry sites (IRES) elements |
DE10143237A1 (en) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Manufacture of artificial internal ribosomal entry point elements (Ires elements) |
CN1668634A (en) | 2002-05-22 | 2005-09-14 | 比奥根艾迪克Ma公司 | Detection of secreted polypeptides |
US7119187B2 (en) | 2002-07-09 | 2006-10-10 | National Health Research Institutes | Internal ribosome entry site of the labial gene for protein expression |
GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
WO2004009788A2 (en) * | 2002-07-19 | 2004-01-29 | Diversa Corporation | Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
US7344886B2 (en) | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
AU2003300932A1 (en) | 2002-12-16 | 2004-07-29 | Wayne State University | Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
EP3346010A1 (en) | 2003-06-24 | 2018-07-11 | Genzyme Corporation | Novel beta-actin and rps21 promoters and uses thereof |
US7776584B2 (en) | 2003-08-01 | 2010-08-17 | Genetix Limited | Animal cell colony picking apparatus and method |
US20070178072A1 (en) | 2004-03-31 | 2007-08-02 | Kirin Beer Kabushiki Kaisha | Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
US7078179B2 (en) | 2004-05-04 | 2006-07-18 | Newlink Genetics Corporation | Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase |
WO2006023248A2 (en) * | 2004-07-28 | 2006-03-02 | The Trustees Of Columbia University In The City Of New York | Processes for producing and crystallizing g-protein coupled receptors |
SI1809750T1 (en) | 2004-11-08 | 2012-08-31 | Chromagenics Bv | Selection of host cells expressing protein at high levels |
CA2581422C (en) | 2004-11-08 | 2012-05-22 | Chromagenics B.V. | Selection of host cells expressing protein at high levels |
CN101068928A (en) * | 2004-12-14 | 2007-11-07 | 弗·哈夫曼-拉罗切有限公司 | Method for improved selection of rnai transfectants |
KR101087809B1 (en) | 2006-04-10 | 2011-11-29 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Systems for collection of single cells and colonies |
ES2388003T3 (en) | 2006-09-20 | 2012-10-05 | Genzyme Corporation | A system based on FACS and the indicator protein for high-performance development of therapeutic proteins |
WO2008106730A1 (en) * | 2007-03-05 | 2008-09-12 | Newsouth Innovations Pty Limited | Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents |
JP6039552B2 (en) * | 2010-07-01 | 2016-12-07 | グラクソ グループ リミテッドGlaxo Group Limited | Improved method for selecting high producer cell lines |
CA2868398A1 (en) * | 2012-04-02 | 2013-10-10 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
EP2970956A1 (en) | 2013-03-11 | 2016-01-20 | Novartis AG | Method of screening cell clones |
SG11201802829YA (en) | 2015-10-09 | 2018-05-30 | Genzyme Corp | Early post-transfection isolation of cells (epic) for biologics production |
US20180119192A1 (en) | 2016-10-07 | 2018-05-03 | Genzyme Corporation | Early post-transfection isolation of cells (epic) for biologics production |
-
2016
- 2016-10-07 SG SG11201802829YA patent/SG11201802829YA/en unknown
- 2016-10-07 CA CA3001238A patent/CA3001238A1/en active Pending
- 2016-10-07 EP EP16788603.5A patent/EP3359666A1/en active Pending
- 2016-10-07 IL IL258538A patent/IL258538B2/en unknown
- 2016-10-07 SG SG11201802823VA patent/SG11201802823VA/en unknown
- 2016-10-07 US US15/288,036 patent/US11635363B2/en active Active
- 2016-10-07 IL IL258537A patent/IL258537B1/en unknown
- 2016-10-07 CN CN201680072391.5A patent/CN108368505B/en active Active
- 2016-10-07 CN CN202310124801.8A patent/CN116660127A/en active Pending
- 2016-10-07 IL IL309289A patent/IL309289A/en unknown
- 2016-10-07 CA CA3001364A patent/CA3001364A1/en active Pending
- 2016-10-07 AU AU2016335699A patent/AU2016335699A1/en not_active Abandoned
- 2016-10-07 CN CN201680071815.6A patent/CN108368504B/en active Active
- 2016-10-07 MX MX2018004366A patent/MX2018004366A/en unknown
- 2016-10-07 EP EP16788602.7A patent/EP3359665A2/en active Pending
- 2016-10-07 IL IL297805A patent/IL297805A/en unknown
- 2016-10-07 US US15/288,050 patent/US10317329B2/en active Active
- 2016-10-07 SG SG10202111233SA patent/SG10202111233SA/en unknown
- 2016-10-07 WO PCT/US2016/055918 patent/WO2017062724A1/en active Application Filing
- 2016-10-07 WO PCT/US2016/055915 patent/WO2017062722A2/en active Application Filing
-
2019
- 2019-02-01 HK HK19101915.9A patent/HK1259493A1/en unknown
- 2019-04-23 US US16/392,174 patent/US20200018682A1/en active Pending
-
2022
- 2022-11-25 AU AU2022275507A patent/AU2022275507A1/en active Pending
-
2023
- 2023-03-10 US US18/181,803 patent/US20230304913A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3001364A1 (en) | 2017-04-13 |
IL297805A (en) | 2022-12-01 |
CA3001238A1 (en) | 2017-04-13 |
SG11201802829YA (en) | 2018-05-30 |
CN116660127A (en) | 2023-08-29 |
IL258537A (en) | 2018-05-31 |
IL258538B (en) | 2022-12-01 |
AU2022275507A1 (en) | 2023-02-02 |
CN108368505B (en) | 2023-02-21 |
CN108368504A (en) | 2018-08-03 |
CN108368504B (en) | 2022-07-19 |
US20230304913A1 (en) | 2023-09-28 |
CN108368505A (en) | 2018-08-03 |
US20170227441A1 (en) | 2017-08-10 |
WO2017062722A2 (en) | 2017-04-13 |
IL258538A (en) | 2018-05-31 |
MX2018004366A (en) | 2018-08-01 |
AU2016335699A1 (en) | 2018-05-24 |
SG11201802823VA (en) | 2018-05-30 |
IL309289A (en) | 2024-02-01 |
US20170121734A1 (en) | 2017-05-04 |
IL258538B2 (en) | 2023-04-01 |
US10317329B2 (en) | 2019-06-11 |
US20200018682A1 (en) | 2020-01-16 |
WO2017062724A1 (en) | 2017-04-13 |
EP3359666A1 (en) | 2018-08-15 |
WO2017062722A3 (en) | 2017-05-26 |
US11635363B2 (en) | 2023-04-25 |
HK1259493A1 (en) | 2019-11-29 |
IL258537B1 (en) | 2024-01-01 |
EP3359665A2 (en) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1259493A1 (en) | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting | |
HK1243463A1 (en) | Compositions and methods for detecting an rna virus | |
ZA201701168B (en) | Antibodies, compositions, and uses | |
HK1258249A1 (en) | Gene signatures for determining icos expression | |
IL276695B (en) | Antibodies, pharmaceutical compositions and uses thereof | |
PL3322544T3 (en) | Material sorting system | |
HK1245350A1 (en) | Compositions and methods for screening t cells with antigens for specific populations | |
SG11201605580RA (en) | Antibodies directed against interleukin-33 (il-33) | |
GB201501791D0 (en) | Non-linear echo path detection | |
GB2531564B (en) | Apparatus for separating particles from an airflow | |
HK1211390A1 (en) | Bypass path loss reduction | |
EP3169614A4 (en) | High rate bulk flow sortation | |
GB2516999B (en) | An improved return stack buffer | |
IL259673A (en) | Improved cytometric assays | |
IL251282A0 (en) | Anti-il-7r antibody compositions | |
EP3350593A4 (en) | Threshold selector for flow cytometer | |
IL251606A0 (en) | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease | |
ZA201700734B (en) | Flow cytometry assembly and system, analysing device comprising such a cytometry assembly and assembly comprising such a cytometry system | |
EP3167274A4 (en) | Flow cytometry apparatus and methods | |
PL3259000T3 (en) | Apparatus for high gas flow | |
IL247100A0 (en) | Anti cd84 antibodies, compositions comprising same and uses thereof | |
EP3271149A4 (en) | Detecting airborne particles | |
PL3178929T3 (en) | New anti-human ig(beta) antibody | |
IL237852A0 (en) | Anti amphiregulin antibodies, compositions comprising same and uses thereof | |
PL3307657T3 (en) | Apparatus for sorting objects |